Skip to main content
Premium Trial:

Request an Annual Quote

BGI Extends Offer for Complete Genomics Until March 14

NEW YORK (GenomeWeb News) – BGI said today that it has extended its cash tender offer for Complete Genomics until 11:59 PM EDT, March 14.

The deadline for the approximately $118 million deal, which has been extended numerous times, previously had been midnight EST March 1. Last week BGI said that the Ministry of Commerce of the People's Republic of China had approved the deal but that it was still awaiting approval by China's State Administration of Foreign Exchange.

The depositary for the offer has indicated that as of the close of business on March 1, more than 30.7 million shares, or 87 percent, of Complete's stock had been validly tendered and not withdrawn, BGI said.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.